Provided by Tiger Fintech (Singapore) Pte. Ltd.

COEPTIS THERAPEUTICS HOLDINGS INC

11.06
+0.61005.84%
Post-market: 11.330.2650+2.40%19:39 EDT
Volume:35.36K
Turnover:393.35K
Market Cap:35.85M
PE:-34.93
High:11.40
Open:10.50
Low:10.50
Close:10.45
Loading ...

Coeptis Therapeutics Holdings Inc trading resumes

TIPRANKS
·
02 Jan

Coeptis Therapeutics Holdings Inc trading halted, news pending

TIPRANKS
·
31 Dec 2024

Why Is Coeptis Therapeutics Stock Falling On Friday?

Benzinga
·
28 Dec 2024

Coeptis Therapeutics to Implement 1-for-20 Reverse Stock Split

MT Newswires Live
·
27 Dec 2024

Coeptis Therapeutics announces 1-for-20 reverse stock split

TIPRANKS
·
27 Dec 2024

Coeptis Therapeutics Announces Reverse Stock Split

THOMSON REUTERS
·
27 Dec 2024

Coeptis Therapeutics Announces Reverse Stock Split

PR Newswire
·
27 Dec 2024

Coeptis Therapeutics Makes Bold Strides in Innovation With the Acquisition of Nexgenai Affiliates Network Platform and Launch of Coeptis Technologies

THOMSON REUTERS
·
26 Dec 2024

Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies

PR Newswire
·
26 Dec 2024

Coeptis Therapeutics Holdings Inc: Signs Binding Loi to Acquire Key Assets From a Risk Mitigation Software Co

THOMSON REUTERS
·
12 Dec 2024

Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies

PR Newswire
·
12 Dec 2024

Coeptis Therapeutics Executes Binding Letter of Intent to Acquire AI-Powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries

THOMSON REUTERS
·
03 Dec 2024

Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries

PR Newswire
·
03 Dec 2024

BRIEF-Coeptis Therapeutics Announces Phase 1 Data On DVX201 For Covid-19 Treatment Has Been Accepted For Publication In Molecular Therapy Methods And Clinical Development

Reuters
·
07 Nov 2024

Coeptis Therapeutics Announces Phase 1 Data on Dvx201 for Covid-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development

THOMSON REUTERS
·
07 Nov 2024

Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development

PR Newswire
·
07 Nov 2024